Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Oral tobacco products: preference and effects among smokers.

Hatsukami DK, Jensen J, Anderson A, Broadbent B, Allen S, Zhang Y, Severson H.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):230-6. doi: 10.1016/j.drugalcdep.2011.03.026. Epub 2011 Apr 23.

PMID:
21515003
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Prevalence of trial of snus products among adult smokers.

Biener L, McCausland K, Curry L, Cullen J.

Am J Public Health. 2011 Oct;101(10):1874-6. doi: 10.2105/AJPH.2010.200097. Epub 2011 Feb 17.

PMID:
21330582
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Oral manifestations of smokeless tobacco use.

Greer RO Jr.

Otolaryngol Clin North Am. 2011 Feb;44(1):31-56, v. doi: 10.1016/j.otc.2010.09.002. Review.

PMID:
21093622
[PubMed - indexed for MEDLINE]
4.

Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.

Kotlyar M, Hertsgaard LA, Lindgren BR, Jensen JA, Carmella SG, Stepanov I, Murphy SE, Hecht SS, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):91-100. doi: 10.1158/1055-9965.EPI-10-0349. Epub 2010 Nov 10. Erratum in: Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):1048.

PMID:
21068204
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Test marketing of new smokeless tobacco products in four U.S. cities.

Rogers JD, Biener L, Clark PI.

Nicotine Tob Res. 2010 Jan;12(1):69-72. doi: 10.1093/ntr/ntp166. Epub 2009 Nov 16.

PMID:
19917598
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Receptivity to Taboka and Camel Snus in a U.S. test market.

Biener L, Bogen K.

Nicotine Tob Res. 2009 Oct;11(10):1154-9. doi: 10.1093/ntr/ntp113. Epub 2009 Jun 29.

PMID:
19564175
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.

Stepanov I, Jensen J, Hatsukami D, Hecht SS.

Nicotine Tob Res. 2008 Dec;10(12):1773-82. doi: 10.1080/14622200802443544.

PMID:
19023828
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study.

Luo J, Ye W, Zendehdel K, Adami J, Adami HO, Boffetta P, Nyrén O.

Lancet. 2007 Jun 16;369(9578):2015-20.

PMID:
17498797
[PubMed - indexed for MEDLINE]
9.

Tobacco-specific nitrosamines in new tobacco products.

Stepanov I, Jensen J, Hatsukami D, Hecht SS.

Nicotine Tob Res. 2006 Apr;8(2):309-13.

PMID:
16766423
[PubMed - indexed for MEDLINE]
10.

Tobacco-specific nitrosamines in smokeless tobacco products marketed in India.

Stepanov I, Hecht SS, Ramakrishnan S, Gupta PC.

Int J Cancer. 2005 Aug 10;116(1):16-9.

PMID:
15756678
[PubMed - indexed for MEDLINE]
11.

The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts.

Levy DT, Mumford EA, Cummings KM, Gilpin EA, Giovino G, Hyland A, Sweanor D, Warner KE.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2035-42.

PMID:
15598758
[PubMed - indexed for MEDLINE]
Free Article
12.

Smokeless tobacco use: harm reduction or induction approach?

Hatsukami DK, Lemmonds C, Tomar SL.

Prev Med. 2004 Mar;38(3):309-17. Review.

PMID:
14766113
[PubMed - indexed for MEDLINE]
13.

Surveillance of smokeless tobacco nicotine, pH, moisture, and unprotonated nicotine content.

Richter P, Spierto FW.

Nicotine Tob Res. 2003 Dec;5(6):885-9.

PMID:
14668072
[PubMed - indexed for MEDLINE]
14.

European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.

Bates C, Fagerström K, Jarvis MJ, Kunze M, McNeill A, Ramström L.

Tob Control. 2003 Dec;12(4):360-7.

PMID:
14660767
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Oral spit tobacco: addiction, prevention and treatment.

Hatsukami DK, Severson HH.

Nicotine Tob Res. 1999 Mar;1(1):21-44. Review.

PMID:
11072386
[PubMed - indexed for MEDLINE]
16.

Pharmacokinetics and pharmacodynamics of moist snuff in humans.

Fant RV, Henningfield JE, Nelson RA, Pickworth WB.

Tob Control. 1999 Winter;8(4):387-92.

PMID:
10629244
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines.

Hecht SS.

Chem Res Toxicol. 1998 Jun;11(6):559-603. Review. No abstract available.

PMID:
9625726
[PubMed - indexed for MEDLINE]
18.

Smokeless tobacco: an addicting drug.

Henningfield JE, Fant RV, Tomar SL.

Adv Dent Res. 1997 Sep;11(3):330-5. Review.

PMID:
9524433
[PubMed - indexed for MEDLINE]
19.

Chemical composition and carcinogenicity of smokeless tobacco.

Hoffmann D, Djordjevic MV.

Adv Dent Res. 1997 Sep;11(3):322-9. Review.

PMID:
9524432
[PubMed - indexed for MEDLINE]
20.

Environmental exposure to N-nitroso compounds (NNOC) and precursors: an overview.

Bartsch H, Spiegelhalder B.

Eur J Cancer Prev. 1996 Sep;5 Suppl 1:11-7. Review. No abstract available.

PMID:
8972287
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk